Provided by Tiger Trade Technology Pte. Ltd.

Oncolytics Biotech Inc

0.6310
-0.0102-1.59%
Post-market: 0.64990.0189+3.00%19:57 EDT
Volume:611.81K
Turnover:384.76K
Market Cap:80.46M
PE:-1.96
High:0.6521
Open:0.6521
Low:0.6211
Close:0.6412
52wk High:1.42
52wk Low:0.6211
Shares:127.51M
Float Shares:122.97M
Volume Ratio:0.71
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3215
EPS(LYR):-0.3000
ROE:-10187.64%
ROA:-211.24%
PB:-13.05
PE(LYR):-2.10

Loading ...

Oncolytics Biotech to present data at ASCO 2026 on pelareorep

TIPRANKS
·
May 22

Oncolytics Biotech presents ASCO 2026 data from pelareorep trials in GI tumors

Reuters
·
May 22

Oncolytics net loss more than doubled to $9.24 million in Q1 2026

Reuters
·
May 15

Lake Street Sticks to Its Buy Rating for Oncolytics Biotech (ONCY)

TIPRANKS
·
May 05

BRIEF-Oncolytics Biotech® Reports Durable Responses In Second-Line Ras-Mutant Mss Colorectal Cancer

Reuters
·
May 04

Oncolytics says pelareorep combo shows 19.5-month response duration in Phase 2 mCRC study

Reuters
·
May 04

Oncolytics Biotech Inc - 2L Kras-Mutant Mss Mcrc Demonstrates 3-4X Improvement in Duration of Response VS. Historical 4-6 Month Benchmark

THOMSON REUTERS
·
May 04

Oncolytics Biotech Inc - Pelaeoreorep Combination Shows 19.5-Month Median Duration of Response in 2L Kras-Mutant Mss Mcrc

THOMSON REUTERS
·
May 04

Oncolytics Biotech Inc - Engaged With FDA on Accelerated Approval Pathway for 2L Ras-Mutant Mss Mcrc

THOMSON REUTERS
·
May 04

Analysts Have Conflicting Sentiments on These Healthcare Companies: Oncolytics Biotech (ONCY) and Agilon Health (AGL)

TIPRANKS
·
Apr 28

Oncolytics says in alignment with FDA following pelareorep Type C meeting

TIPRANKS
·
Apr 27

Oncolytics Biotech Inc - Announces Alignment With FDA on Pivotal Anal Cancer Study - SEC Filing

THOMSON REUTERS
·
Apr 27

Oncolytics aligns with FDA on pivotal pelareorep anal cancer trial design

Reuters
·
Apr 27

Top News Today: Stocks Rise Amid Hopes for Further U.S.-Iran Talks

Dow Jones
·
Apr 17

Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)

TIPRANKS
·
Apr 07

Oncolytics Biotech signs Jefferies ATM equity sale agreement for up to $75 million

Reuters
·
Apr 07

Oncolytics Biotech Inc - to Offer and Sell Common Stock up to $75 Mln Through Jefferies - SEC Filing

THOMSON REUTERS
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget

Reuters
·
Apr 06

BUZZ-Oncolytics rises as it schedules FDA talks on anal cancer drug

Reuters
·
Apr 06